Acute Kidney Injury and Critical Care Nephrology
Acute kidney injury (AKI) is an abrupt decline in kidney function — measured as a rise in serum creatinine and/or a fall in urine output over hours to days — and is one of the most common organ dysfunctions encountered in hospitalized and critically ill patients. This area orients the reader to how AKI is defined and staged, the principal mechanisms and syndromes that cause it, and the role of nephrology within critical care, including extracorporeal organ support.
Definition
Acute kidney injury is a clinical syndrome of rapid (hours to days) deterioration of kidney function, defined by KDIGO as an increase in serum creatinine, a decrease in urine output, or both, beyond defined thresholds; critical care nephrology is the subdiscipline concerned with AKI and kidney support in critically ill patients.
Scope
The area gathers the conceptual and clinical essentials of AKI and critical care nephrology: the consensus classification systems (RIFLE, AKIN, KDIGO), the major causal categories and specific syndromes (acute tubular necrosis, contrast-associated AKI, rhabdomyolysis-associated AKI), and renal replacement therapy as it is used in the intensive care unit. It treats these as reference topics for understanding pathophysiology and evidence, not as clinical protocols.
Sub-topics
Core questions
- How is acute kidney injury defined, staged, and distinguished from chronic kidney disease?
- What are the prerenal, intrinsic (especially acute tubular necrosis), and postrenal categories of AKI?
- Which specific syndromes — contrast-associated AKI, rhabdomyolysis-associated AKI — illustrate distinct mechanisms?
- When and how is renal replacement therapy used to support critically ill patients with AKI?
- How does an episode of AKI relate to longer-term kidney outcomes?
Key concepts
- AKI definition and staging (KDIGO criteria)
- Serum creatinine and urine output as functional markers
- Prerenal, intrinsic, and postrenal categories
- Acute tubular necrosis
- AKI-to-CKD transition
- Renal replacement therapy in the ICU
- Fluid balance and hemodynamic support
Mechanisms
AKI arises through reduced renal perfusion (prerenal), direct injury to the nephron — most often the tubular epithelium (intrinsic, classically acute tubular necrosis), and obstruction to urine flow (postrenal). In critically ill patients these mechanisms frequently overlap: sepsis, hypovolemia, nephrotoxins, and hemodynamic instability act together, and the resulting loss of glomerular filtration manifests as a rising serum creatinine and falling urine output. Chawla and colleagues describe how an episode of AKI is not always fully reversible and can set the stage for chronic kidney disease, framing AKI and CKD as interconnected syndromes rather than separate events.
Clinical relevance
AKI is a frequent complication in hospital and intensive care settings and is associated with increased morbidity, longer hospital stays, and adverse long-term kidney outcomes; recognizing and characterizing it is central to critical care medicine and nephrology. This entry describes the concepts and evidence that underpin AKI care and is not a substitute for individualized clinical assessment or management.
Epidemiology
AKI affects a substantial fraction of hospitalized patients and a majority of those in intensive care units when consensus definitions are applied, with sepsis, major surgery, and nephrotoxic exposures among the leading contributors; severity by KDIGO stage tracks with worse outcomes, and even mild AKI is associated with later development of or progression to chronic kidney disease.
Evidence & guidelines
The 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury provides the prevailing international definition and staging framework and synthesizes evidence on prevention, evaluation, and management, building on the earlier RIFLE and AKIN criteria. Narrative reviews by Ronco and colleagues and by Kellum and Prowle summarize the pathophysiology and critical-care perspective.
History
AKI was long described as 'acute renal failure,' a term that lacked a standard definition. The introduction of the RIFLE criteria (2004) and the AKIN modification (2007) created graded, consensus definitions, which the 2012 KDIGO guideline harmonized and extended. In parallel, the growth of critical care nephrology established extracorporeal kidney support as a routine part of intensive care, and recognition of the AKI-to-CKD link reframed AKI as a condition with long-term consequences.
Debates
- How should renal replacement therapy be timed in critically ill AKI?
- Whether to start renal replacement therapy earlier or to wait for conventional indications has been tested in several randomized trials with differing results, and the optimal timing strategy remains an active question.
Key figures
- John A. Kellum
- Claudio Ronco
- Rinaldo Bellomo
- Lakhmir S. Chawla
Related topics
Seminal works
- khwaja-2012
- ronco-2019
- chawla-2014
Frequently asked questions
- What is the difference between acute kidney injury and chronic kidney disease?
- AKI is an abrupt decline in kidney function over hours to days that may be reversible, whereas CKD is a sustained reduction in kidney function over months or years; the two are linked, because an AKI episode can contribute to or unmask CKD.
- Why is AKI staged?
- Staging by KDIGO criteria, using changes in serum creatinine and urine output, provides a standardized measure of severity that correlates with outcomes and supports consistent description and research.